Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Somerset › NPI 1417452798
Clinic

Crossroads Treatment Center of Somerset, PSC

Crossroads Treatment Center of Somerset, PSC was paid $7.19M by Medicaid between Sep 2018 and Dec 2024, across 24 billing codes. Its largest line is H0020, Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) — 77% of everything it billed.

33Billing provider infoCROSSROADS TREATMENT CENTER OF SOMERSET, PSC
SOMERSET, KY 42503
33aNPI1417452798assigned 03/28/2018
33bProvider typeMethadone Clinic
28Total paid$7.19M
24GClaims210,345
24DCodes billed24
24AFirst – last monthSep 2018 – Dec 2024
Compared with peers

Next to other Methadone Clinic providers in Kentucky

Rank by total paid#4 of 16
Median peer was paid$4.29M
This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MCCORMAC, RUPERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,579$24K
201969,560$589K
202065,315$1.54M
202116,515$1.26M
202216,859$1.23M
202320,222$1.41M
2024incomplete20,295$1.13M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
H0020 Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) 77% 85,659 17,926 $5.52M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 9.6% 89,248 3,489 $691K
T1007 Alcohol and/or substance abuse services, treatment plan development and/or modification 4.5% 5,445 4,517 $324K
99408 1.7% 7,626 614 $123K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.5% 2,304 2,119 $107K
H0016 Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) 1.3% 583 519 $95K
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient 1.0% 4,257 1,384 $73K
H0033 Oral medication administration, direct observation <1% 912 758 $71K
99441 <1% 5,647 1,391 $63K
90791 Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation <1% 1,558 1,089 $56K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity <1% 1,552 1,248 $31K
82075 <1% 2,750 2,400 $26K
12 more codes
90834 Psychotherapy session, about 45 minutes <1% 61 $2K
99204 Doctor's office visit, new patient (more involved) <1% 122 $2K
99406 <1% 293 $1K
86580 <1% 321 $1K
G2067 Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) <1% 263 $1K
36415 Collection of venous blood by venipuncture <1% 324 $1K
80305 <1% 331 $778.46
99203 Doctor's office visit, new patient (routine) <1% 13 $533.66
81025 <1% 120 $413.11
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 389 $156.59
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 0% 175 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 0% 392 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCCORMAC, RUPERT (CHIEF EXECUTIVE OFFICER)
Same official

Other billing entities under MCCORMAC, RUPERT

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.